Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Cholangiocarcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Mouth Neoplasms 1Metastatic NUT Carcinoma 1Laryngeal Neoplasms 1Klatskin Tumor 1Infiltrating Bladder Urothelial Carcinoma 1Hypopharyngeal Neoplasms 1HIV Infections 1Carcinoma 1Borderline Resectable Pancreatic Adenocarcinoma 1Bile Duct Neoplasms 1

Interventions

ricolinostat 1Platinum 1Gemcitabine 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Klatskin Tumor × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT02856568 2017-05-30

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Mayo Clinic

Phase 1 Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡